Weibo Looks To Raise Up To $1.2B Via Syndicated Debt Offering
Yesterday, 3:01 PM
Weibo Corp (NASDAQ:WB) pursued up to $1.2 billion in syndicated financings inspired by other Chinese social media platforms, Bloomberg reports.…
ThermoGenesis Reported in Filing Tuesday It Received a Conversion Notice From Boyalife Asset Holding II to Convert a Total of $3M of the Outstanding Balance of the Second Amended and Restated Convertible Promissory Note Issued to Boyalife on April 16,…
Yesterday, 9:23 AM
On June 28, 2022, ThermoGenesis Holdings, Inc. (the "Company") received a conversion notice from Boyalife Asset Holding II, Inc.("Boyalife") to convert a total of $3,000,000 of the outstanding balance of the Second Amended and Restated Convertible Promissory Note issued by the Company to Boyalife on April 16, 2018, as amended by Amendment No 1 thereto dated March 4, 2022 (as amended, the "Note").
Agile Therapeutics Announces Pricing of $24M Upsized Public Offering
July 1, 9:22 AM
Agile Therapeutics, Inc. (NASDAQ:AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the pricing of its upsized public offering of an aggregate of
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 1, 8:53 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:
Field Trip Shares Fiscal Q4 And Full Year 2022 Results & Update On Court-Approved Corporate Reorganization
June 30, 8:34 PM
Psychedelic therapies developer and provider Field Trip Health Ltd.
Transphorm Files For Resale Of Up To 3.9M Shares Of Common Stock By Selling Stockholders
June 29, 4:34 PM
-Reuters
Verrica Announces Proposed Public Offering of Common Stock, Terms Not Disclosed
June 29, 4:02 PM
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it intends to offer and sell, subject to